Year Established :
2009
Total Assets(USD) :
Choose not to disclose
Total Number of Staff :
30 to 39
Main Competitive Advantages :
International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Contract Manufacturing,Small Orders Accepted,Reputation,Quality Service
Business Type :
Manufacturer,Trading Company
Annual Turnover(USD) :
3,000,000 to 3,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Main Product Categorise :
Active Pharmaceutical Ingredients,Intermediates,Fine Chemicals,Custom Manufacturing
Product Range :
main products include intermediates of capecitabine, clofarabine,gefitinib,erlotinib and gemcitabine.